Host-Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement

Itraconazole is an antifungal agent included in the triazole pharmacological classification that belongs to the BCS class II, characterized by a low solubility in an aqueous medium (of 1 ng/mL, at neutral pH), which is frequently translated in a low oral bioavailability but with a high permeability....

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Lenuţa-Maria Şuta (Dahkki), Amalia Ridichie (Dahkki), Adriana Ledeţi (Dahkki), Claudia Temereancă (Dahkki), Ionuţ Ledeţi (Dahkki), Delia Muntean (Dahkki), Matilda Rădulescu (Dahkki), Renata-Maria Văruţ (Dahkki), Claudia Watz (Dahkki), Florentin Crăineanu (Dahkki), Denisa Ivan (Dahkki), Gabriela Vlase (Dahkki), Lavinia Stelea (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: MDPI AG, 2024-04-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_0af0efcfa90a4d749bc5f1714b6a3efc
042 |a dc 
100 1 0 |a Lenuţa-Maria Şuta  |e author 
700 1 0 |a Amalia Ridichie  |e author 
700 1 0 |a Adriana Ledeţi  |e author 
700 1 0 |a Claudia Temereancă  |e author 
700 1 0 |a Ionuţ Ledeţi  |e author 
700 1 0 |a Delia Muntean  |e author 
700 1 0 |a Matilda Rădulescu  |e author 
700 1 0 |a Renata-Maria Văruţ  |e author 
700 1 0 |a Claudia Watz  |e author 
700 1 0 |a Florentin Crăineanu  |e author 
700 1 0 |a Denisa Ivan  |e author 
700 1 0 |a Gabriela Vlase  |e author 
700 1 0 |a Lavinia Stelea  |e author 
245 0 0 |a Host-Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement 
260 |b MDPI AG,   |c 2024-04-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics16040560 
500 |a 1999-4923 
520 |a Itraconazole is an antifungal agent included in the triazole pharmacological classification that belongs to the BCS class II, characterized by a low solubility in an aqueous medium (of 1 ng/mL, at neutral pH), which is frequently translated in a low oral bioavailability but with a high permeability. In this sense, it is necessary to find solutions to increase/improve the solubility of itraconazole in the aqueous environment. The main purpose of this study is the preparation and analysis of five different guest-host inclusion complexes containing intraconazole. Initially, a blind docking process was carried out to determine the interactions between itraconazole and the selected cyclodextrins. The second step of the study was to find out if the active pharmaceutical ingredient was entrapped in the cavity of the cyclodextrin, by using spectroscopic and thermal techniques. Also, the antifungal activity of the inclusion complexes was studied to examine if the entrapment of itraconazole influences the therapeutic effect. The results showed that the active substance was entrapped in the cavity of the cyclodextrins, with a molar ratio of 1:3 (itraconazole-cyclodextrin), and that the therapeutic effect was not influenced by the entrapment. 
546 |a EN 
690 |a itraconazole 
690 |a cyclodextrins 
690 |a inclusion complex 
690 |a TG 
690 |a antifungal activity 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 16, Iss 4, p 560 (2024) 
787 0 |n https://www.mdpi.com/1999-4923/16/4/560 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/0af0efcfa90a4d749bc5f1714b6a3efc  |z Connect to this object online.